Tonix Pharmaceuticals Announces Conditional Acceptance of Tonmya as Proposed Brand Name for TNX-102 SL (Cyclobenzaprine HCl Sublingual Tablets) for the Treatment of PTSD

NEW YORK, July 06, 2017 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix) a company that is developing innovative pharmaceutical products to address public health challenges today reported that the U.S. Food and Drug...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news

Related Links:

Publication date: Available online 24 May 2019Source: Journal of Psychiatric ResearchAuthor(s): Laura D. Crocker, Sarah M. Jurick, Kelsey R. Thomas, Amber V. Keller, Mark Sanderson-Cimino, Samantha N. Hoffman, Briana Boyd, Carie Rodgers, Sonya B. Norman, Ariel J. Lang, Elizabeth W. Twamley, Amy J. JakAbstractSome providers have expressed hesitation about the appropriateness of PTSD treatment for veterans with a history of mild traumatic brain injury (mTBI), given concerns that TBI-related sequelae may negatively affect PTSD treatment and/or should be the focus of treatment instead. However, research suggests that those wit...
Source: Journal of Psychiatric Research - Category: Psychiatry Source Type: research
Condition:   PTSD Intervention:   Behavioral: trauma-focused treatment Sponsor:   VA Office of Research and Development Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
This study examined the unique effects of MSA on IPV victimization of, and perpetration by, women Veterans, and investigated posttraumatic stress disorder (PTSD) symptoms and prior IPV victimization as potential mediators of IPV perpetration. Participants included 187 women Veterans drawn from a larger web-based survey. We assessed the two components of MST (MSA and harassment) at Time 1 (T1), PTSD symptoms at Time 2 (T2), IPV victimization at T2 and Time 3 (T3), and IPV perpetration at T3. MSA predicted multiple subtypes of IPV victimization and perpetration, whereas harassment predicted neither. Those who reported MSA we...
Source: Journal of Family Violence - Category: Psychiatry & Psychology Source Type: research
CONCLUSION At least 20 years after injury, no correlation was found between the development of psychiatric complications and the severity of injury. While the rate of full-blown PTSD was low, nearly half the study population regularly suffered from at least one psychiatric symptom attributable to the initial trauma. Awareness for the development of psychiatric complications and early initiation of psychiatric counseling are advisable. LEVEL OF EVIDENCE Prognostic and epidemiologic, level II.
Source: The Journal of Trauma: Injury, Infection, and Critical Care - Category: Orthopaedics Tags: ORIGINAL ARTICLES Source Type: research
Nightmares are a regular part of life for many people that suffer from post-traumatic stress disorder (PTSD). They can be very hard to control, since dreams seem to have a life of their own and arise in our sleep whether we want them to or not. Night...
Source: Medgadget - Category: Medical Devices Authors: Tags: Medicine Net News Psychiatry Rehab Source Type: blogs
Publication date: July 2019Source: Biomedicine &Pharmacotherapy, Volume 115Author(s): Ai-shan Su, Jun-wei Zhang, Jing ZouAbstractPost traumatic stress disorder (PTSD) is a mental illness that affected numerous people. The anti-PTSD-like effects of puerarin is unknown, although the antidepressant- and anxiolytic- like effects of puerarin have been reported. The PTSD behavioral deficits in rats were induced by single prolonged stress (SPS), mainly including the reduced time/entries in the open arms and the elevated time/entries in the closed arms in elevated plus maze test, increased freezing duration in contextual fear ...
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
Conditions:   Depression;   Anxiety;   PTSD;   Suicidal Ideation;   Substance Use Disorders;   Unsafe Sex;   Coping Behavior Intervention:   Behavioral: AWARE intervention Sponsors:   Boston University Charles River Campus;   Harvard University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Post-traumatic Stress Disorder Intervention:   Drug: ketamine-enhanced prolonged exposure Sponsor:   Minneapolis Veterans Affairs Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
A new study shows that some groups may be more susceptible to PTSD. Licensed psychologist Dr. Wendy Dickinson joined CBSN to talk about the study's findings.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
Could a chatbot, an online community, or a telepsychiatry solution offer meaningful help for people who are fighting mental health issues? Could virtual reality, artificial intelligence, or genetics appear as elements of assistance in the toolkit of medical professionals in the fields dealing with the human psyche? While we agree that medical fields requiring the most empathy and human touch will most probably not be swept away by new innovations, we looked thoroughly at how technology will appear in the future of psychiatry. Perhaps even help heal the cursed prince from Beauty and the Beast? The human touch is indispen...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Future of Medicine Virtual Reality in Medicine AI apps AR artificial intelligence digital health digital health technologies health apps Innovation mental health psychiatry psychology technology VR Source Type: blogs
More News: Cyclobenzaprine | Drugs & Pharmacology | International Medicine & Public Health | New Drug Applications | Post Traumatic Stress Disorder